Clinical Trial Update: Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating pharmacokinetics of tipped boosted protease inhibitor therapy (tipranavir/ritonavir) in highly treatment-experienced HIV-1 infec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• tipranavir/ritonavir (tipranavir/ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 2 | Status: COMPLETED